Respiratory Medicine
37+ Years Experience
MD; FRCP ( Glasgow) ; DTRD
Apollo Hospitals Greams Road Chennai
English,Hindi,Telugu,Tamil
Mon - Sat
12:00 -17:30
Respiratory Medicine
37+ Years Experience
MD; FRCP ( Glasgow) ; DTRD
Apollo Hospitals Greams Road Chennai
English,Hindi,Telugu,Tamil
Mon - Sat
12:00 -17:30
Dr. Ilangho R P is a highly experienced Pulmonology Respiratory Medicine Specialist based in Chennai, Tamil Nadu. With an impressive 37 years of clinical practice, he has established himself as a trusted physician in the field of respiratory health. Dr. Ilangho's extensive qualifications include an MBBS, MD, FRCP, and DTRD, showcasing his deep commitment to medical education and professional excellence. As a part of the Apollo group, he utilizes advanced medical technologies and protocols to provide exceptional care to his patients.
Fluent in multiple languages including English, Hindi, Tamil, Telugu, and Malayalam, Dr. Ilangho is dedicated to ensuring that a diverse patient base can communicate effectively regarding their health concerns. His expertise encompasses a wide range of respiratory conditions, making him a critical resource for patients seeking specialized care for ailments such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders.
Patients appreciate Dr. Ilangho's compassionate approach and thorough understanding of the latest advancements in pulmonology. Whether it’s through comprehensive consultations or personalized treatment plans, he strives to empower his patients with the knowledge and tools necessary to manage their conditions effectively. Dr. Ilangho R P is not only a skilled practitioner but also a patient advocate who is dedicated to improving the quality of life for those with respiratory challenges.
‘Apollo Hospitals Proceedings’, since its inception in planning, design and content,
2003 till closure.
EDUCATION :
·MBBS
Stanley Medical College, Chennai, India – November 1986
?DTRD (Diploma in Tuberculosis and Respiratory Diseases) #
Madras Medical College, Chennai, India – April 1990
# University (State) First-Rank
?MD
Stanley Medical College, Chennai, India – April 1995
Royal College of Physicians and Surgeons of Glasgow, Glasgow, United Kingdom
–June 2007
PROFESSIONAL MEMBERSHIPS
1. PRESIDENT: Indian Medical Association, Apollo Hospitals - Thousand- lights branch, Chennai
2. Indian Association of Bronchology-Life Member.
3. Indian Medical Association-Life Member.
4. Indian Chest Society – Life member. ACCP (American College of Chest Physicians) – USA– Indian Chapter- Life Member. Association of Physicians of India –Life member.
5. Indian Critical Care Society – Life Member.
6. Fellow of Royal College of Physicians & Surgeons of Glasgow, United Kingdom.
7. VICE-PRESIDENT of FIRST ASSOCIATION OF PULMONOLOGISTS OF TAMILNADU- 2016 [APT] Member, Editorial Board, of FIRST Journal of Association of Pulmonologists of Tamilnadu [JAPI] 2016 Founder Member of Organizing Committee: FIRST TAPPCON Conference -Tamilnadu and Pondicherry Pulmonology Conference-2015 & 2016
8. Member: former-The Global Advisory Board of: The Disease Management Association of India (DMAI)
Member: former-Institutional Ethical Committee -The Tamilnadu Dr. M.G.R Medical University, Chennai, India.
RESEARCH AND PUBLICATIONS
Many in National & International Journals & Peer Reviewer for them.
Principle Investigator, of Phase IV, Open-label, non-comparative, multicentric, trial, titled ‘Use of Meropenem in the treatment of Moderate and Severe Infections’ in 2003.
Investigator (Unblinded Physician) in, global, multicenter, double-blind, comparative, randomized, Phase III trial, to evaluate `The efficacy and safety of Micafungin versus Liposomal Amphotericin B in the treatment of Invasive Candidiasis and Candidaemia`, between 2003 to 2004.
Investigator (Unblinded Physician) in Phase III, global, randomized double-blind comparative study of`` Micafungin versus Caspofungin as an antifungal treatment in patients with Invasive Candidiasis and Candidaemia`, in 2005.
Abovementioned trials subjected to US FDA audit
Trained in ICH-GCP (International Conference on Harmonisation Regulations - Good Clinical Practices).
*Centre Principal Investigator, in the Writing Group of the Global Asthma Network Study Group- 2013 till date
Drug Trials -various @ - Apollo Hospitals ,Chennai , India.
obstructive airway diseases in Indian population.”European Respiratory Society,
International Congress, 2015.
ERS- European Respiratory Society --2017
A] Evaluation of Asthma Control using ACQ & comparison with GINA criteria
Amarendra P ,Ilangho RP
B} Risk factors in OSA
Meghna, Ilangho RP
12. R Narasimhan,B Rajagopalan,C Chandrasekhar,R Velraj, Ilangho Rp et al
:Comprehensive Overview and Evidence Based Clinical Approach to Covid- 19 - An Official Consensus Statement Endorsed By Association of
Pulmonologist of Tamilnadu, Journal of Association of Pulmonologist of Tamil Nadu ; 20203(4):1.DOI: 10.4103/WKMP-0215.309207
13. VaseemaThabassum Shaik, Ilangho Rp, K Bhaskaran :Utility of Ariscat (Assess respiratory risk in surgical patients in catalonia) score in predicting postoperative pulmonary complications in patients undergoing
elective/emergency surgery in a tertiary care Hospital in India.Journal of Association of Pulmonologist of Tamil Nadu, 2021; 4(3):94. DOI: 10.4103/japt.japt_38_21